Otologic Pharmaceutics otologicpharmaceutics.com


Public lists: Pharma Startups (6570)

Otologic Pharmaceutics (OPI) is a development-stage biopharmaceutical company committed to developing and commercializing novel pharmacological solutions and approaches to treat hearing disorders. OPI's lead product, HPN1010, an oral treatment for Acute Hearing Loss, is scheduled to enter clinical trials in 2014. Extensive pre-clinical research, done collaboratively through OMRF and HEI supported by nearly $ 5.4 million from the Department of Defense, has demonstrated the potential effectiveness...Show all

Otologic Pharmaceutics (OPI) is a development-stage biopharmaceutical company committed to developing and commercializing novel pharmacological solutions and approaches to treat hearing disorders. OPI's lead product, HPN1010, an oral treatment for Ac...Show all

Company (Alive / Active)

Phone: 405-319-8165

Fax:

865 Research Parkway
Suite 400
Oklahoma City, 73104
Oklahoma, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Otologic Pharmaceutics $4.1M Apr 3, 2014

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Otologic Pharmaceutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 7 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)